Evidence map›Paper›PMID 38682058›Full record

ArticleIranian journal of microbiology2024

Investigating the therapeutic potential of

Nafiseh Erfanian, Hossein Safarpour, Tahmineh Tavakoli, Mohammad Ali Mahdiabadi, Saeed Nasseri, Mohammad Hassan Namaei

Abstract read
In one paragraph

Article in Iranian journal of microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Anticancer Potential ofInternational journal of molecular sciences · 2026
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Postbiotics: an insightful review of the latest category in functional biotics.World journal of microbiology & biotechnology · 2025
    Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Anticancer Effects ofLife (Basel, Switzerland) · 2024
    Article
  16. Probiotics: truths and illusions.Iranian journal of microbiology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Nafiseh ErfanianStudent Research Committee, Birjand University of Medical Sciences, Birjand, Iran.
Hossein SafarpourCellular and Molecular Research Center, Birjand University of Medical Sciences, Birjand, Iran.
Tahmineh TavakoliDepartment of Internal Medicine, School of Medicine, Birjand University of Medical Sciences, Birjand, Iran.
Mohammad Ali MahdiabadiDepartment of Internal Medicine, School of Medicine, Birjand University of Medical Sciences, Birjand, Iran.
Saeed NasseriCellular and Molecular Research Center, Birjand University of Medical Sciences, Birjand, Iran.
Mohammad Hassan NamaeiInfectious Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Objectives: Colorectal cancer (CRC) is a prevalent form of cancer worldwide. Recent studies suggest that postbiotics derived from probiotic bacteria have the potential as an adjunct therapy for CRC. This study investigates the anti-cancer effects of Materials and Methods: Through MTT and scratch assay, we investigated the anti-proliferation and anti-migration effects of Results: The results demonstrated the significant impact of postbiotics on HT-29 cells, highlighting their ability to induce anti-proliferation, anti-migration, and apoptosis-related effects. Notably, these effects were more pronounced using Conclusion: Our research suggests that postbiotic metabolites may be effective biological products for the prevention and treatment of cancer.

Indexed as

ApoptosisBifidobacterium breveColorectal cancerLactobacillus rhamnosusPostbioticsProbiotics

Identifiers

PMID38682058
PMCPMC11055435

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.